Locanabio Stock

Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

Sign up today and learn more about Locanabio Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Locanabio Stock

Locanabio, Inc., is an RNA-targeting gene therapy company focused on developing therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

Funding History

May 2019$55.0M
June 2019$550K
December 2020$100M

Management

Scientific Advisory Board Member

Edward Conner

Chairman

Thomas Daniel

Board member

Cayce Denton

SVP of Technical Operations

Adam Fowler

Board Member

Rajul Jain

CSO

Kathie Bishop

CEO

James Burns

Chief Scientific Officer

John Leonard

Vice President of Human Resources

Holly D. Chrzanowski

Chief Financial Officer

Kat Lange

Co-Founder

Gene Yeo

Press

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo